{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Tilray Brands, Inc."},"Symbol":{"label":"Symbol","value":"TLRY"},"Address":{"label":"Address","value":"265 TALBOT STREET WEST,SUITE 1900, NEW YORK, New York, N8H 5L4, United States"},"Phone":{"label":"Phone","value":"+1 844 845-7291"},"Industry":{"label":"Industry","value":" Medicinal Chemicals and Botanical Products "},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater."},"CompanyUrl":{"label":"Company Url","value":"https://www.tilray.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Irwin David Simon","title":"Chairman, President & Chief Executive Officer"},{"name":"Lloyd Brathwaite","title":"Chief Information Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}